Latest Safety News

Ventia Services Group has upgraded its FY25 profit guidance following a strong first half marked by record contract wins and an expanded share buyback program.

Orora Limited reported a 24.4% increase in FY25 revenue to A$2.09 billion, marking the completion of its strategic portfolio reshaping with the sale of its North American packaging business. The company advances sustainability targets while maintaining steady dividends and a share buyback program.

Anatara Lifesciences reported a 35% rise in net loss to $1.95 million for FY25, following pivotal Phase II trial results for its GaRP product that missed the primary efficacy endpoint but showed promising secondary benefits. The company is advancing commercialisation efforts and launching a new anti-obesity project amid tightened cash reserves.

New Zealand Coastal Seafoods Limited has completed a major vessel upgrade, attracted international investment, and is preparing to resume ASX trading after strategic corporate changes.

Evolution Mining has delivered a landmark FY25 with record profits and cash flow, tripling its final dividend, while setting a stable production and cost outlook for FY26 amid ongoing project developments and sustainability commitments.

AGL Energy Limited posted a statutory loss of $98 million for FY25, while underlying profit declined 21.2% to $640 million. The company reaffirmed its commitment to a renewable energy transition with a 9.6 GW development pipeline and declared a fully franked final dividend of 25 cents per share.

Evolution Mining Limited has reported a landmark FY25 with statutory net profit soaring 119% to $926.2 million and record gold and copper output across its portfolio. Key projects like Mungari’s mill expansion and Cowal’s open pit extension are progressing ahead of schedule, underpinning a confident outlook.

Amotiv Limited reported a modest 1% revenue increase to $997.4 million in FY25 but posted a net loss of $106.3 million, driven by a significant $200.4 million impairment. The company declared a fully franked final dividend of 22 cents per share and outlined strategic initiatives to navigate ongoing market challenges.

Recce Pharmaceuticals’ RECCE 327 Topical Gel shows statistically significant superiority over standard antibiotics in treating antibiotic-resistant burn wounds in preclinical models, advancing its U.S. Department of Defense collaboration.

Life360 reported record Q2 2025 results with robust subscription growth and raised full-year guidance, alongside a strategic leadership transition appointing Lauren Antonoff as CEO.

Life360, Inc. reported a return to profitability in Q2 2025, driven by strong subscription growth and strategic partnerships, while also announcing a leadership transition and issuing $320 million in convertible notes.

LGI Limited reported a robust FY25 with 14% EBITDA growth driven by expanded renewable energy capacity and carbon credit sales, while setting ambitious FY26 guidance of 25-30% EBITDA growth.